Cynthia Seidel-Dugan
Net worth: 1 M $ as of 30/03/2024
Career history of Cynthia Seidel-Dugan
Former positions of Cynthia Seidel-Dugan
Companies | Position | Start | End |
---|---|---|---|
WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2019 | 28/03/2024 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 30/04/2014 | 30/11/2018 |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | 30/04/2013 | 31/01/2014 |
Training of Cynthia Seidel-Dugan
University of Pennsylvania | Doctorate Degree |
The College of William & Mary | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
WEREWOLF THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Cynthia Seidel-Dugan
- Experience